Tumor cell loaded thermosensitive hydrogel for photodynamic therapy associated tumor antigens release

Biochim Biophys Acta Gen Subj. 2024 Nov;1868(11):130703. doi: 10.1016/j.bbagen.2024.130703. Epub 2024 Aug 18.

Abstract

Background: Immunotherapy is a powerful strategy for treating cancer and can be used to inhibit the post-surgical relapse of tumors.

Methods: To achieve this, a Cell@hydrogel was developed as a template using a mixture of CT26 tumor cells and Pluronic® F-127/gelatin.

Results: The proposed mixture has a solution-to-gelation functionality and vice versa. The morphology of the Cell@hydrogel was characterized by scanning electron microscopy and confocal microscopy. For photodynamic immunotherapy, the Cell@hydrogel was functionalized with Cy7 (Cy7-Cell@hydrogel) to quantify reactive oxygen species in CT26 tumor cells. Gel electrophoresis and membrane integrity tests were performed to determine the efficiency of the Cy7-Cell@hydrogel following photodynamic therapy.

Conclusions: This protocol provides an alternative approach that mechanistically inhibits the post-surgical relapse of solid tumors based on immunotherapy.

Keywords: Gelatin; Hydrogel; Immunotherapy; Photodynamic; Pluronic® F-127.

MeSH terms

  • Animals
  • Antigens, Neoplasm* / immunology
  • Antigens, Neoplasm* / metabolism
  • Cell Line, Tumor
  • Humans
  • Hydrogels* / chemistry
  • Immunotherapy* / methods
  • Mice
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Poloxamer / chemistry
  • Reactive Oxygen Species / metabolism

Substances

  • Hydrogels
  • Antigens, Neoplasm
  • Reactive Oxygen Species
  • Photosensitizing Agents
  • Poloxamer